(Q35192539)

7 August 2017

1 reference

title

Getting muscles moving again after botulinum toxin: novel therapeutic challenges (English)

1 reference

7 August 2017

Frederic A Meunier

3

0 references

author name string

Patrick G Foran

series ordinal

1

1 reference

PubMed ID

12900216

7 August 2017

Bazbek Davletov

series ordinal

2

1 reference

7 August 2017

1 July 2003

1 reference

Trends in Molecular Medicine

7 August 2017

1 reference

7 August 2017

9

1 reference

7 August 2017

291-299

1 reference

7 August 2017

7

1 reference

How botulinum and tetanus neurotoxins block neurotransmitter release.

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Botulinum Toxin as a Biological Weapon: Medical and Public Health Management

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Clostridium botulinum and the ophthalmologist: a review of botulism, including biological warfare ramifications of botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Crystal structure of botulinum neurotoxin type A and implications for toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Botulism: the agent, mode of action of the botulinum neurotoxins, forms of acquisition, treatment and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

The bacterial toxin toolkit

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Pathways followed by ricin and Shiga toxin into cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Tetanus and botulinum neurotoxins: turning bad guys into good by research

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Clostridial neurotoxins: new tools for dissecting exocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Translocation of botulinum neurotoxin light chain protease through the heavy chain channel.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Monitoring secretory membrane with FM1-43 fluorescence

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: a new hypothesis to explain persistence of botulinum A poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Persistence of botulinum neurotoxin action in cultured spinal cord cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Development of vaccines for prevention of botulism

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Correlation of cleavage of SNAP-25 with muscle function in a rat model of Botulinum neurotoxin type A induced paralysis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

A high-affinity competitive inhibitor of type A botulinum neurotoxin protease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

High-throughput fluorogenic assay for determination of botulinum type B neurotoxin protease activity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Discovery and design of novel inhibitors of botulinus neurotoxin A: targeted 'hinge' peptide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

Development of a delivery vehicle for intracellular transport of botulinum neurotoxin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2803%2900113-8

7 January 2021

10.1016/S1471-4914(03)00113-8

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12900216